Chan Henry Lee - 06 Mar 2026 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role: SVP, General Counsel
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: ONC
Transactions as of: 06 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 10 Mar 2026, 20:13:45 UTC
Previous filing: 06 Feb 2026
Next filing: 13 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lee Chan Henry	SVP, General Counsel	C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND	/s/ Qing Nian, as Attorney-in-Fact	10 Mar 2026	0001980648

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONC	Ordinary Shares	Award		+65,390	+29%	$0.000000^*	288,496	06 Mar 2026	Direct	F1
transaction	ONC	Ordinary Shares	Award		+29,874	+10%	$0.000000^*	318,370	06 Mar 2026	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events.
F2	Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2028, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events.